Gland Pharma boosts drug stocks as weak rupee enhances margins
Gland Pharma's shares surged 15% as the rupee fell to a record low of 96.34, boosting margins and export revenues. Other pharma stocks also rallied, with gains of 9-16% in recent weeks, benefiting from increased global demand for generics.
pre-market1 source ↓written by the desknot a recommendation
- recently
- 9-16%
India's pharma sector saw a surge as the rupee hit a record low of 96.34, boosting margins and export revenues. Gland Pharma's shares rose 15% on Monday, benefiting from 95% of its revenue coming from overseas, especially the U.S. Other major players like Divi's Labs and Aurobindo Pharma also rallied between 9-16% recently.
The falling rupee is a significant advantage for Indian pharma companies, enhancing their dollar-denominated revenues and margins, especially amid rising global demand for generic drugs. 📈
Not investment advice. For informational purposes only.